Aarti Drugs (BOM:524348) Long-Term Debt : ₹2,753 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Aarti Drugs Long-Term Debt?

Aarti Drugs's Long-Term Debt for the quarter that ended in Mar. 2024 was ₹2,753 Mil.

Aarti Drugs's quarterly Long-Term Debt declined from Sep. 2023 (₹2,121 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹2,753 Mil).

Aarti Drugs's annual Long-Term Debt increased from Mar. 2022 (₹1,385 Mil) to Mar. 2023 (₹2,047 Mil) and increased from Mar. 2023 (₹2,047 Mil) to Mar. 2024 (₹2,753 Mil).

Aarti Drugs Long-Term Debt Historical Data

The historical data trend for Aarti Drugs's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs Long-Term Debt Chart

Aarti Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

Get a 7-Day Free Trial

1,803.12

1,475.59

1,384.99

2,046.77

2,753.30

Aarti Drugs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															2,046.77	-	2,121.00	-	2,753.30

Aarti Drugs (BOM:524348) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Aarti Drugs Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Aarti Drugs's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Aarti Drugs (BOM:524348) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » Long-Term Debt

Traded in Other Exchanges

AARTIDRUGS:India

Address

Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400 022

Website

https://www.aartidrugs.co.in

Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm generates the majority of its revenue from India.

Aarti Drugs (BOM:524348) Headlines

No Headlines